These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12473289)
1. Is a Chlamydia vaccine a reality? Christiansen G; Birkelund S Best Pract Res Clin Obstet Gynaecol; 2002 Dec; 16(6):889-900. PubMed ID: 12473289 [TBL] [Abstract][Full Text] [Related]
2. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge. Pal S; Theodor I; Peterson EM; de la Maza LM Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566 [TBL] [Abstract][Full Text] [Related]
3. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research. Wen Z; Boddicker MA; Kaufhold RM; Khandelwal P; Durr E; Qiu P; Lucas BJ; Nahas DD; Cook JC; Touch S; Skinner JM; Espeseth AS; Przysiecki CT; Zhang L BMC Microbiol; 2016 Jul; 16(1):165. PubMed ID: 27464881 [TBL] [Abstract][Full Text] [Related]
4. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection. Wang L; Cai Y; Xiong Y; Du W; Cen D; Zhang C; Song Y; Zhu S; Xue X; Zhang L Oncotarget; 2017 May; 8(20):33241-33251. PubMed ID: 28402260 [TBL] [Abstract][Full Text] [Related]
5. Chlamydia trachomatis: Protective Adaptive Responses and Prospects for a Vaccine. Poston TB; Darville T Curr Top Microbiol Immunol; 2018; 412():217-237. PubMed ID: 27033698 [TBL] [Abstract][Full Text] [Related]
6. A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo. Knight SC; Iqball S; Woods C; Stagg A; Ward ME; Tuffrey M Immunology; 1995 May; 85(1):8-15. PubMed ID: 7543450 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection. Jiang P; Du W; Xiong Y; Lv Y; Feng J; Zhu S; Xue X; Chen S; Zhang L Oncotarget; 2015 Dec; 6(41):43281-92. PubMed ID: 26657117 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine. Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158 [TBL] [Abstract][Full Text] [Related]
9. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge. Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110 [TBL] [Abstract][Full Text] [Related]
10. Transcervical Inoculation with Chlamydia trachomatis Induces Infertility in HLA-DR4 Transgenic and Wild-Type Mice. Pal S; Tifrea DF; Zhong G; de la Maza LM Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29038126 [No Abstract] [Full Text] [Related]
11. Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model. Jiang P; Cai Y; Chen J; Ye X; Mao S; Zhu S; Xue X; Chen S; Zhang L Vaccine; 2017 May; 35(23):3096-3103. PubMed ID: 28456528 [TBL] [Abstract][Full Text] [Related]
12. Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance. Desclozeaux M; Robbins A; Jelocnik M; Khan SA; Hanger J; Gerdts V; Potter A; Polkinghorne A; Timms P PLoS One; 2017; 12(6):e0178786. PubMed ID: 28575080 [TBL] [Abstract][Full Text] [Related]
13. Towards a Chlamydia trachomatis vaccine: how close are we? Cochrane M; Armitage CW; O'Meara CP; Beagley KW Future Microbiol; 2010 Dec; 5(12):1833-56. PubMed ID: 21155665 [TBL] [Abstract][Full Text] [Related]
14. In silico design and analysis of a multiepitope vaccine against Chlamydia. Tanner T; Medhavi FNU; Richardson S; Omosun YO; Eko FO Pathog Dis; 2024 Feb; 82():. PubMed ID: 38889932 [TBL] [Abstract][Full Text] [Related]
15. Advances in vaccine development for Chlamydia trachomatis. Poston TB Pathog Dis; 2024 Feb; 82():. PubMed ID: 39043447 [TBL] [Abstract][Full Text] [Related]
16. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Eko FO; Lubitz W; McMillan L; Ramey K; Moore TT; Ananaba GA; Lyn D; Black CM; Igietseme JU Vaccine; 2003 Apr; 21(15):1694-703. PubMed ID: 12639492 [TBL] [Abstract][Full Text] [Related]
17. Vaccines against Chlamydia: approaches and progress. Stagg AJ Mol Med Today; 1998 Apr; 4(4):166-73. PubMed ID: 9572058 [TBL] [Abstract][Full Text] [Related]
18. Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects. Hafner LM; Timms P Expert Rev Vaccines; 2018 Jan; 17(1):57-69. PubMed ID: 29264970 [TBL] [Abstract][Full Text] [Related]
19. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen. Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689 [TBL] [Abstract][Full Text] [Related]
20. A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice. Tu J; Hou B; Wang B; Lin X; Gong W; Dong H; Zhu S; Chen S; Xue X; Zhao KN; Zhang L Acta Biochim Biophys Sin (Shanghai); 2014 May; 46(5):401-8. PubMed ID: 24681882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]